An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators
Authors:
- 20 March 2017
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 16 (5) , 491-502
Abstract
Introduction: Development of efficient and cost effective vaccines have been recognized as the primary concern to improve the overall healthcare in a country. In order to achieve this goal, more improved and powerful adjuvants need to be developed. Lacking in the self-adjuvanting immuno-modulatory constituents, vaccines exhibit lower immunogenicity. Combining potent adjuvants with vaccines is the most appropriate method to enhance the efficacy of the vaccines. Hence, this review is focussed on the most potent adjuvants for the formulation of vaccines. Areas covered: This review focuses on Oil-based emulsions, Mineral compounds, Liposomes, Bacterial products, ISCOMs and most recently used nanomaterials as adjuvants for enhancing the antigenicity of vaccines. Furthermore, this review explains the immunological response elicited by various particles. Moreover, case studies are incorporated providing an in depth analyses of various adjuvant-containing vaccines which are currently used. Expert commentary: Enhanced fundamental knowledge about the adjuvants and their immuno-stimulatory capabilities and delivery mechanisms will facilitate the rational designing of prophylactic vaccines with better efficacy.Keywords
This publication has 138 references indexed in Scilit:
- New views on cellular uptake and trafficking of manufactured nanoparticlesJournal of The Royal Society Interface, 2013
- Preparation of Colloidal Mesoporous Silica Nanoparticles with Different Diameters and Their Unique Degradation Behavior in Static Aqueous SystemsChemistry of Materials, 2012
- GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older AdultsThe Journal of Infectious Diseases, 2011
- Synthesis of a novel kind of carbon nanoparticle with large mesopores and macropores and its application as an oral vaccine adjuvantEuropean Journal of Pharmaceutical Sciences, 2011
- Vaccine adjuvants – Current status and prospects on controlled release adjuvancitySaudi Pharmaceutical Journal, 2011
- Single-Walled Carbon Nanotubes Deliver Peptide Antigen into Dendritic Cells and Enhance IgG Responses to Tumor-Associated AntigensACS Nano, 2011
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Construction and Immunological Evaluation of Multivalent Hepatitis B Virus (HBV) Core Virus-Like Particles Carrying HBV and HCV EpitopesClinical and Vaccine Immunology, 2010
- Transcutaneous Immunization withClostridium difficileToxoid A Induces Systemic and Mucosal Immune Responses and Toxin A-Neutralizing Antibodies in MiceInfection and Immunity, 2007
- New strategies for using mucosal vaccination to achieve more effective immunizationVaccine, 1994